Abstract:Multiple system atrophy (MSA) is a neurodegenerative disorder with variable disease course and distinct constellations of clinical (cerebellar [MSA-C] or parkinsonism [MSA-P]) and pathological phenotypes, suggestive of distinct α-synuclein (αSyn) strains. Neuropathologically, MSA is characterized by the accumulation of αSyn in oligodendrocytic glial cytoplasmic inclusions (GCI). Using a novel computer-based method, this study quantified the size of GCIs, density of all αSyn pathology, density of only the GCIs, and number of GCIs in MSA cases (n = 20). The putamen and cerebellar white matter were immunostained with the disease-associated 5G4 anti-αSyn antibody. Following digital scanning and image processing, total 5G4-immunoreactive pathology (ie, neuronal, neuritic, and glial) and GCIs were optically dissected for inclusion size and density measurement and then evaluated applying a novel computer-based method using ImageJ. GCI size varied between cases and brain regions (P < .0001), and heterogeneity in the density of all αSyn pathology including the density and number of GCIs were observed between regions and across cases, where MSA-C cases had a significantly higher density of all αSyn pathology in the cerebellar white matter (P = .049). Some region-specific morphologic variables inversely correlated with the age of onset and death, suggestive of an underlying aging-related cellular mechanism. Unsupervised K-means cluster analysis classified MSA cases into 3 distinct groups based on region-specific morphologic variables. In conclusion, we developed a novel computer-based method that is easily accessible, providing a first step to developing artificial intelligence-based evaluation strategies for large scale comparative studies. Our observations on the variability of morphologic variables between brain regions and cases highlight (1) the importance of computer-based approaches to detect features not considered in the routine diagnostic practice, and (2) novel aspects for the identification of previously unrecognized MSA subtypes that do not necessarily reflect the current clinical classification of MSA-C or MSA-P.

Multiple system atrophy: Diagnostic challenges and a proposed diagnostic algorithm

A Review on the Clinical Diagnosis of Multiple System Atrophy

Candidate biomarkers of multiple system atrophy in cerebrospinal fluid

New advances in multiple system atrophy

Multiple System Atrophy: Pathology, Pathogenesis, and Path Forward

Imaging Markers of Multiple System Atrophy and Their Association With Disease Severity: A Cross-Sectional Study

Neuroimaging Features of Multiple System Atrophy

Multiple System Atrophy: Recent Developments and Future Perspectives

Surface-Based Neuroimaging Pattern of Multiple System Atrophy

Computer-Based Evaluation of α-Synuclein Pathology in Multiple System Atrophy as a Novel Tool to Recognize Disease Subtypes

Clinical and Pathological Characteristics of Multiple System Atrophy

In Vivo Cerebral Metabolic and Dopaminergic Characteristics in Multiple System Atrophy with Orthostatic Hypotension.

Diagnostic utility of fluid biomarkers in multiple system atrophy: a systematic review and meta-analysis

Dilemma of multiple system atrophy and spinocerebellar ataxias

Cerebrospinal fluid myelin basic protein is elevated in multiple system atrophy

Advances in the Diagnosis and Treatment of Multiple System Atrophy

Improving the Accuracy of Diagnosis for Multiple-System Atrophy Using Deep Learning-Based Method

Diagnostic utility of movement disorder society criteria for multiple system atrophy

The Movement Disorder Society Criteria for the Diagnosis of Multiple System Atrophy

Multiple system atrophy: an update and emerging directions of biomarkers and clinical trials

Multiple System Atrophy: Advances in Diagnosis and Therapy